Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kapil Gururangan MD

Kapil Gururangan MD

Fellow in Epilepsy and Clinical Neurophysiology, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California

Dr. Kapil Gururangan is currently a fellow in epilepsy and clinical neurophysiology at University of California Los Angeles. He received his medical degree from Stanford University and completed his neurology residency at The Mount Sinai Hospital, where he served as chief resident and was awarded an NINDS R25 training grant. After completing his training, he will be joining the epilepsy faculty of Northwestern University as an assistant professor in the department of neurology.

Dr. Gururangan’s clinical and research interests include surgical and neuromodulatory treatment of drug-resistant epilepsy, diagnosis and management of nonconvulsive status epilepticus, brain tumor-related epilepsy, and electroencephalography education. He also serves as a clinical and scientific advisor to Ceribell Inc., a medical device startup company that commercializes an artificial intelligence-enabled point-of-care rapid EEG system for detecting nonconvulsive seizures and status epilepticus.


Dr. Gururangan has no relevant financial disclosures or conflicts of interest. He receives consulting fees from Ceribell, Inc., for research activities unrelated to this commentary.